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Volume 55, Number 5 Abstracts 1541Summary: There has been a surge of interest in endovascular interven-
tions for acute carotid occlusion (Zaidat OO et al, Neurosurgery 2004;55:
1237-43; Dabitz R et al, Cardiovasc Intervent Radiol 2007;30:34-41; and
Miyamoto N, Neurol Med Chir (Tokyo) 2008;48:49-56). Recanalization
rates have been better than expected (50% to 65%), with improvement in
neurologic status in some patients. In one study, mortality was 30% with
recanalization of the ICA but was 73% in the non-recanalized patients (Flin
AC, Stroke 2007;38:1274-80). In this current article, the authors’ results
with emergency endovascular carotid recanalization in patients with acute
proximal (cervical) ICA occlusion are presented, focusing on success rates,
predictors of recanalization, and neurologic and functional outcome. Inclu-
sion criteria included a National Institutes of Health Stroke Scale (NIHSS)
score 5, stroke onset within 8 hours of presentation, and computed
tomography (CT) imaging, suggesting salvageable brain tissue. Patients
with hemorrhage or evidence of a completed large ipsilateral stroke on a
noncontrast CTwere excluded. In all cases, occlusion of the cervical ICAwas
confirmed by catheter-based angiography. The authors’ technique involved
initially advancing a platform guide catheter into the common carotid artery
just proximal to the bifurcation. They then explored the carotid artery
bifurcation with a microcatheter and microwire, with subsequent advance-
ment of a mircocatheter into the petrocavernous segment of the carotid
artery. If distal patency could not be demonstrated, the procedure was
aborted. If distal patency was present or could be restored, they attempted to
restore flow in the cervical ICA. This series consisted of 22 patients under-
going emergency endovascular revascularization for acute stroke secondary
to cervical ICA occlusion. Patients were a mean age of 65 years with a mean
admission NIHSS score of 14. Recanalization was established in 17 patients
(77.3%). Ten patients (45.5 %) had significant clinical improvement during
the course of their hospitalization (NIHSS score improvement 4 points).
At a median follow-up of 3 months, 50% patients had outcomes with
modified Rankin scales 2. Age 70 years and successful recanalization
predicted a good outcome (P  .01). Poor outcome was associated with
ICA occlusion at all levels (cervical, petrocavernous, and intracranial) as well
as atrial fibrillation. Patients with complete cervical ICA occlusion, but
partial distal preservation of the ICA, were most likely to achieve benefit
from the intervention, (recanalization, 88.2%; good outcome, 64.7%).
Comment: The results of this review are not “what dreams are made
of,” but they may be better than the natural history of acute symptomatic
cervical ICA occlusion. However, it is possible the patients who do the best
would have done reasonably well even without interventional treatment.
The approach advocated here must be tempered with knowledge of hemor-
rhage risk and pretreatment infarct size. The outcome was favorable in 50%
of patients. However, all patients with initial complete carotid artery occlu-
sion, including the intracranial segments, died or were severely disabled,
suggesting that attempts at endovascular recanalization of the cervical ICA
should be limited to patients with partial reconstitution of the ICA above the
level of the cervical ICA occlusion.
Adapted from Moneta G et al. 2012 Year Book of Vascular Surgery.
Philadelphia, PA: Elsevier; 2012; with permission.
Health-Related Quality of Life After Carotid Stenting Versus Carotid
Endarterectomy: Results from CREST (Carotid Revascularization
Endarterectomy Versus Stenting Trial)
Cohen DJ, Stolker JM, Wang K, and the CREST Investigators.J Am Coll
Cardiol 2011;58:1557-65.
Conclusion: Carotid artery stenting (CAS) and carotid endarterec-
tomy (CEA) are associated with similar overall health-related quality of life
(HRQOL) at 1 year. Stroke has a greater and more consistent sustained
impact on HRQOL than myocardial infarction (MI).
Summary: The Carotid Revascularization Endarterectomy Versus
Stenting Trial (CREST) trial compared CAS and CEA in patients at low risk
of surgical complications for carotid intervention. There were no differences
in the primary composite end point of stroke, MI, or death 4 years of
follow-up. However, individual end points varied between treatment
groups, with patients assigned to CAS having higher rates of stroke and
patients assigned to CEA having higher rates of MI. Previous studies have
suggested less patient impairment during early recovery after CAS compared
with CEA. However, differences were brief and limited to highly sensitive
disease-specific outcomes and physical role limitation (Stolker JM, J AmColl
Cardiol Interv 2010;3:515-23). These studies were also small or enrolled
highly selected patients. The current report is a prospectively planned
analysis of HRQOL among patients randomly assigned to CAS or CEA in
the CREST study. The authors measured HRQOL at baseline and after 2
weeks, 1 month, and 1 year among 2502 patients in the CREST study. The
Medical Outcomes Study Short-Form 36 (SF-36) and six disease-specific
scales to study HRQOL in patients undergoing carotid revascularization
were used in this study. At 2 weeks and 1 month, CAS patients had better
outcomes for multiple components of the SF-36. There were large differ-
ences for the physical function role, pain, and physical component summary
scales (all P  .01). CAS patients reported less difficulty with driving,
eating/swallowing, neck pain, and headaches but more difficulty with
walking and leg pain (all P  .05). At 1 year, there were no differences in
HRQOL measurements between CAS and CEA. Periprocedural stroke was
P
0ssociated with poor HRQOL at 1 year across all SF-36 domains, but
eriprocedural MI or cranial nerve palsy were not.
Comment:Overall HRQOL at 1 year in CEA vs CAS patients was not
ifferent. Because complications ofMI and stroke were relatively infrequent,
he effects of complications on HRQOL are likely mitigated by the large
umber of patients who did not have complications. What this study says is
hat the effects of stroke as a complication of carotid intervention are worse
or the patient than the effects of MI or cranial nerve injury. Although most
trokes in CREST, as assessed by physician evaluators, were so-called minor
trokes, apparently, as assessed by patients, minor stokesmight not be all that
inor.
Adapted from Moneta G et al. 2012 Year Book of Vascular Surgery.
hiladelphia, PA: Elsevier; 2012; with permission.
mportance of Specimen Length During Temporal Artery Biopsy
psilantis E, Courtney ED, Chopra N, et al. Br J Surg 2011;98:1556-60.
Conclusion: Erythrocyte sedimentation rate (ESR) and length of
emporal artery biopsy (TAB) specimen are independent prognostic factors
or a positive TAB result.
Summary: Giant cell arteritis (GCA) affects medium sized and large
rteries, most commonly the extracranial arteries of the head and neck. GCA
as an incidence of 15 to 25 105 per year in patients aged 50 years and
s more common in woman (Bengtsston BA, Arthritis Rheum 1981;24:899-
04). Because of the potential complication of blindness, treatment with
teroids is often urgently instituted when the diagnosis is suspected. Duplex
ltrasound imaging is an accurate, noninvasive, first-line investigation for
CA. However, treatment is generally based on a TAB specimen, and TAB
s recommended for investigation of GCA (Dasgupta B et al, Rheumatology
010;49:1594-7). The likelihood of a positive TAB may be related to
btaining an adequate length of temporal artery for analysis, but the mini-
um length is debatable. The purpose of this retrospective study was to
xplore potential associations between TAB specimen length and diagnostic
ensitivity. The authors examined histopathologic reports and medical re-
ords of patients who underwent TAB in six hospitals between 2004 and
009. There were 966 biopsy specimens analyzed. Median postfixation
pecimen length was 1 cm (range, 0.1-8.5 cm). There were 207 (21.4%) that
ere positive for GCA. Among hospitals, there were variations in prebiopsy
SR, arterial specimen length, and positive results. By multivariable analysis,
SR value, patient age, and specimen length were independent predictors of
CA. There were longer median specimen lengths in patients with positive
AB results vs those with negative results, 1.2 cm (range 0.3-8.5cm) vs. 1.0
m (range, 0.2-8.0 cm), respectively (P  .001). Specimen length by
eceiver operating characteristic (ROC) curve analysis of at least 0.7 cm was
he cutoff length providing the highest positive predictive value for a positive
AB (area under ROC curve, 0.574). There was a significantly higher rate of
ositive results when the biopsy specimen length was0.7 cm vs specimens
ith a shorter length (24.8% vs 12.9%; odds ratio; 2.17; P  .001).
Comment: Length of the TAB specimen correlates in this study
ositively with diagnostic sensitivity. The study provides a guideline for
inimal length of a TAB specimen. The data here would suggest that a
ength of at least 0.7 cm should be obtained. A uniform pattern of practice
f obtaining a specimen of at least 1 cm in length should help eliminate
iscrepancies between hospitals and the results of TAB.
Adapted from Moneta G et al. 2012 Year Book of Vascular Surgery.
hiladelphia, PA: Elsevier; 2012; with permission.
ong-term Follow-up of Acute type B Aortic Dissection: Ulcer-like
rojections in Thrombosed False Lumen Play a Role in Late Aortic
vents
iyahara S, Mukohara N, Fukuzumi M, et al. J Thorac Cardiovasc Surg
011;142:e25-31
Conclusion: In patients with acute type B aortic dissection, throm-
osed false lumens with ulcer-like projections (ULPs) and patent false
umens have adverse influences on the rate of late aortic dilation and late
ortic events.
Summary: It is known that a patient with type B aortic dissection and
patent false lumen at presentation has a poorer outcome than a patient with
thrombosed false lumen, so-called intramural hematoma. At least 2 types
f intramural hematoma are recognized, those with and without ULPs.
here is controversy over management of thrombosed false lumens with
LPs. The authors compared clinical features and prognosis of type B acute
ortic dissection according to false lumen status: patent, thrombosed, or
LPs in thrombosed false lumens. They identified predictors of late aortic
vents on the basis of the false lumen at presentation. The study enrolled 160
atients. The mean follow-up interval was 44.6 25.4 months. False lumen
tatus was used to divide the patients into three groups: group T, throm-
osed (49 patients, 30.6%); group U, thrombosed false lumen with ULPs
52 patients, 32.5%); and group P, patent false lumen (59 patients, 36.9%).
he mean aortic enlargement rate of groups U (0.40 0.91 mm/mon) and
(0.44  0.49 mm/mon) was greater than that of group T (&endash;
.016 0.23mm/mon).More late events occurred in groups U and P than
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May 20121542 Abstractsgroup T. The 5-year event-free rates were 67.4%  8.2% in group U and
57.7% 10.9% in group P vs 95.04% 4.9% in group T (group T vs group
U: P .001; group U vs group P: P .96; group P vs group T: P .0004).
False lumen status (patent or ULP; P  .29), maximum aortic diameter at
onset (P  .001), and patient age (P  .0069) all were predictors of late
aortic events.
Comment:Widespread availability of thoracic endografts has added to
the controversy about how to manage patients with acute aortic dissection.
At one extreme is to use medical management for all patients except those
with obvious complications of rupture ormalperfusion. At the other extreme
is placement of an endograft for all acute type B aortic dissections regardless
of the presence of complications. A middle ground is to try to determine
which patients with acute type B aortic dissection are at greatest risk for late
aortic events such as late rupture or progressive dilation. Data such as this are
helpful in trying to determine whether a middle ground for acute treatment
of patients with acute aortic dissection is reasonable.
Adapted from Moneta G et al. 2012 Year Book of Vascular Surgery.
Philadelphia, PA: Elsevier; 2012; with permission.
Long-term Outcome After Additional Catheter-Directed Thromboly-
sis Versus Standard Treatment for Acute Iliofemoral Deep Vein
Thrombosis (the CaVen T Study): A Randomised Controlled Trial
Enden T, Haig Y Klow N-E; CaVen T, Study Group. Lancet 2012;379:
31-38.
Conclusion:Catheter-directed thrombolysis (CDT) should be consid-
ered in patients with proximal deep vein thrombosis (DVT) and a low risk of
bleeding.
Summary: Patients with symptomatic DVT of the popliteal and more
proximal veins have up to a 50% incidence of some degree of post-thrombotic
syndrome (PTS; Prandoni P et al. Ann Intern Med 2004;141:249-56). A
recent systematic review suggested thrombus removal lowers the incidence
of PTS (Watson LI et al. Cochrane Database Syst Rev 2004;4:CD002783).
The Catheter-Directed Venous Thrombolysis Study evaluated if the addi- Pion of CDT to standard anticoagulation for iliofemoral venous thrombosis
mproved the long-term prevalence of PTS after iliofemoral DVT. This was
n open-label, randomized, controlled trial. Patients (aged 18-75 years)
ere recruited from 20 hospitals in southeastern Norway. To be included,
he DVT had to be a first-time iliofemoral DVT and patients had to be
ntered into the study21 days of symptom onset. Patients were randomly
ssigned to conventional treatment alone or CDT with alteplase. Random-
zation was stratified for involvement of pelvic veins. The two primary
utcomes were frequency of PTS, as assessed by the Villalta score at 24
onths, and iliofemoral venous patency at 6 months. An intention-to-treat
nalysis was used. There were 209 patients randomly assigned to the
reatment groups (108 to control and 101 to CDT). At 24 months,
ollow-up data for clinical status was available in 189 patients (95%: 99
ontrols, 90 CDTs), and 37 patients (41.1%, 95% confidence interval [CI]
1.5%-51.4%) allocated to additional CDT presented with PTS compared
ith 55 (55.6%, 95%CI, 45.7%-65.0%) in the control group (P .047). The
ifference in PTS corresponds to an absolute risk reduction of 14.4% (95%
I, 0.2%-27.9%), and the number needed to treat was seven (95% CI,
-502). At 6 months, iliofemoral patency was reported in 58 patients
65.9%, 95% CI, 55.5%-75.0%) in the CDT group vs 45 (47.4%, 95% CI,
7.6%-57.3%) in the control group (P  .012). There were 20 bleeding
omplications related to CDT, including three major and five clinically
elevant bleeding events.
Comment: This is the first large randomized trial to show clinically
ignificant reductions in PTS after the use of CDT compared with conven-
ional treatment alone for patients with acute iliofemoral DVT. The effect
as modest, with an absolute risk reduction of 14.4% and a number needed
o treat of seven to prevent one PTS. There was a small additional risk of
leeding in patients treated with CDT. Overall however, the results are
linically significant and support recent guidelines that CDT can be consid-
red in patients with proximal DVT and a low risk of bleeding.Adapted from Moneta G et al. 2012 Year Book of Vascular Surgery.
hiladelphia, PA: Elsevier; 2012; with permission.
